SNP318

N/A

Report date: 2025/10/09 20:00:09
NME

Base Information

Drug NameSNP318
Drug Alias NameSNP318SNP-318
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoprotein-associated phospholipase A2 inhibitors
TargetsLipoprotein-associated phospholipase A2
Therapy Area/IndicationsDiabetic macular oedemaAmyotrophic Lateral SclerosisDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSciNeuro Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesSciNeuro Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaAmyotrophic Lateral SclerosisDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A